Dr Keri Hildick
Chief Strategy Officer
Dr Keri Hildick is the Chief Strategy Officer, responsible for commercial growth and strategic partnerships. Keri oversees the commercialisation of Perspectum’s product portfolio across the life sciences and clinical markets, with an emphasis on market access and reimbursement.
Keri holds a BSc (Hons) in Pharmacology from the University of Edinburgh and a PhD in molecular neurobiology at the University of Bristol. Before joining Perspectum, Keri worked at GlaxoSmithKline in vitro pharmacology and molecular discovery research, and at the Royal Society in Science Communications, before moving into the clinical healthcare sector as a Market Analyst in liver and infectious diseases.